ScreenPro Security Inc. (SCRSF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 135.58 Thousand USD | 158.03% |
| 2022 | -233.66 Thousand USD | -239.88% |
| 2021 | -68.75 Thousand USD | -173.59% |
| 2020 | 93.42 Thousand USD | 87.75% |
| 2019 | 49.76 Thousand USD | 313.61% |
| 2018 | 12.03 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 112.67 Thousand USD | -14.93% |
| 2024 Q2 | 102.58 Thousand USD | 79.25% |
| 2023 Q3 | 38.12 Thousand USD | -38.57% |
| 2023 FY | 135.58 Thousand USD | 158.03% |
| 2023 Q4 | 135.58 Thousand USD | 255.69% |
| 2023 Q2 | 62.05 Thousand USD | 266.25% |
| 2023 Q1 | -37.32 Thousand USD | 84.03% |
| 2022 Q3 | 171.96 Thousand USD | 17.54% |
| 2022 Q1 | -736.85 Thousand CAD | -585.2% |
| 2022 Q4 | -233.66 Thousand USD | -235.88% |
| 2022 FY | -233.66 Thousand USD | -239.88% |
| 2022 Q2 | 146.29 Thousand CAD | 119.85% |
| 2021 Q2 | -777.77 Thousand CAD | -361.54% |
| 2021 Q1 | -168.51 Thousand CAD | -227.53% |
| 2021 Q4 | -107.53 Thousand USD | 8.65% |
| 2021 FY | -68.75 Thousand USD | -173.59% |
| 2021 Q3 | -117.72 Thousand CAD | 84.86% |
| 2020 Q3 | 95.66 Thousand CAD | 10.39% |
| 2020 Q2 | 86.66 Thousand CAD | 11.59% |
| 2020 Q1 | 77.66 Thousand CAD | 13.11% |
| 2020 FY | 93.42 Thousand USD | 87.75% |
| 2020 Q4 | 132.13 Thousand CAD | 38.13% |
| 2019 Q4 | 68.66 Thousand CAD | 0.0% |
| 2019 FY | 49.76 Thousand USD | 313.61% |
| 2018 FY | 12.03 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | 93.854% |
| Arrayit Corporation | 1.05 Million USD | 87.155% |
| Atlantic International Corp. | 236.49 Thousand USD | 42.668% |
| Biocept, Inc. | -788 Thousand USD | 117.207% |
| Bioqual, Inc. | -12 Million USD | 101.129% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | -496.284% |
| DermTech, Inc. | 17.65 Million USD | 99.232% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 100.024% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 101.838% |
| iMD Companies, Inc. | 1.11 Million USD | 87.85% |
| IDenta Corp. | 524.85 Thousand USD | 74.166% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 98.238% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | 603.076% |
| InVitro International | -313.14 Thousand USD | 143.3% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | 91.341% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | 19116.69% |
| Medical Imaging Corp. | 3.79 Million USD | 96.423% |
| NovelStem International Corp. | 3.52 Million USD | 96.15% |
| Optigenex Inc. | 8.93 Million USD | 98.482% |
| PharmChem, Inc. | -1.49 Million USD | 109.073% |
| Proteome Sciences plc | 14.57 Million USD | 99.07% |
| Response Genetics, Inc | -13.08 Million USD | 101.036% |
| Rennova Health, Inc. | 14.82 Million USD | 99.086% |
| RushNet, Inc. | 4.8 Million USD | 97.176% |
| Stella Diagnostics Inc. | 6.19 Million USD | 97.811% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | 92.401% |
| Todos Medical Ltd. | 38.31 Million USD | 99.646% |